A Pioneer of Prescription Wearables By Kelly Roman, CEO & Co-Founder Fisher Wallace Laboratories, the market leader in prescription wearable technology for the treatment of neuropsychiatric disorders, recently announced the closing of a funding round that will provide the company with $2.5M of capital to pursue its growth strategy. The round was led by SHUFL […]
Fisher-Wallace
Medical device startup Fisher Wallace has raised nearly $3 million on StartEngine
Medical device startup Fisher Wallace Laboratories has been named one of “5 Health-Tech Startups to Watch in 2021” by Entrepreneur magazine and has raised nearly $3 million on StartEngine, a leading equity crowdfunding platform. The majority of the company’s investors are its own customers – people who have used Fisher Wallace’s prescription wearable to treat […]
The medical device startup that is disrupting Big Pharma
Fisher Wallace has raised millions via equity crowdfunding to redefine mental health treatment.
FDA proposes to require PMAs for cranial electrotherapy stimulators for depression
The FDA is proposing to require manufacturers of cranial electrotherapy stimulators to submit pre-market approval applications if their devices are intended to treat depression. The federal safety watchdog said it’s also proposing to down-classify CES devices aimed at treating insomnia and anxiety from Class III, which would also require PMA applications, to Class II subject to […]